Cellectar BioSciences shareholders approve 2 million-share increase to 2021 stock incentive plan
CLRB•Shareholders approve stock incentive plan amendment
Cellectar BioSciences held its annual shareholder meeting on July 7, 2026.
- Shareholders authorized an amendment to the 2021 Stock Incentive Plan, increasing the share reserve by 2 million shares.
- Shareholders ratified Deloitte & Touche as independent registered public accounting firm for fiscal 2026.
